Biotech Stocks Facing FDA Decision In December 2022

The FDA, which started 2022, on a slow note, has so far approved 30 novel drugs, compared to 47 that were approved during the same period last year. Now, let's take a look at the biotech stocks facing FDA decision in December.

from RTT - Top Story https://ift.tt/1nBvU80
via IFTTT